Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 10946097 was granted and assigned to NuvOx Pharma on March, 2021 by the United States Patent and Trademark Office. | 10946097 | March 16, 2021 | |||||||
Patent 10456468 was granted and assigned to NuvOx Pharma on October, 2019 by the United States Patent and Trademark Office. | 10456468 | October 29, 2019 | |||||||
Patent 11534492 was granted and assigned to NuvOx Pharma on December, 2022 by the United States Patent and Trademark Office. | 11534492 | December 27, 2022 | |||||||
Patent 11304899 was granted and assigned to NuvOx Pharma on April, 2022 by the United States Patent and Trademark Office. | 11304899 | April 19, 2022 | |||||||
Patent 9700523 was granted and assigned to NuvOx Pharma on July, 2017 by the United States Patent and Trademark Office. | 9700523 | July 11, 2017 | |||||||
Patent 10166200 was granted and assigned to NuvOx Pharma on January, 2019 by the United States Patent and Trademark Office. | 10166200 | January 1, 2019 | |||||||
Patent 10279053 was granted and assigned to NuvOx Pharma on May, 2019 by the United States Patent and Trademark Office. | 10279053 | May 7, 2019 | |||||||
10780060 | September 22, 2020 | ||||||||
Patent 11857627 was granted and assigned to NuvOx Pharma on January, 2024 by the United States Patent and Trademark Office. | 11857627 | January 2, 2024 |